Alnylam Pharmaceuticals Inc at Stifel Healthcare Conference Transcript
With me is Pushkal Garg, the Chief Medical Officer; and Rena Denoncourt, Head of the TTR program, and we're all reminiscing over a great dinner we had last night. So with that, everyone knows the story. There's no need to really set the stage. I think it would be good to talk about TTR and maybe relitigate a little bit of our conversation yesterday.
Questions & Answers
Just related to sort of Helios-B what you're observing in the trial in terms of event rates and what Alnylam's reaction is to a competitor study for Ionis and AstraZeneca functionally being now twice the size because what they're saying is they need that for powering based on how the disease has changed. What's your confidence in your trial and your reaction of what's been going on?
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
